Fresenius Medical Care AG & Co. KGaA ADR (FMS) News

Fresenius Medical Care AG & Co. KGaA ADR (FMS): $15.85

0.27 (+1.73%)

POWR Rating

Component Grades













Filter FMS News Items

FMS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

FMS News Highlights

  • FMS's 30 day story count now stands at 8.
  • Over the past 25 days, the trend for FMS's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • AG, NOV and PFE are the most mentioned tickers in articles about FMS.

Latest FMS News From Around the Web

Below are the latest news stories about FRESENIUS MEDICAL CARE AG & CO KGAA that investors may wish to consider to help them evaluate FMS as an investment opportunity.

Plasmapheresis Machines Market to Witness Huge Growth by Key Players: Fresenius Medical Care, Haemonetics Corporation, Fenwal, Terumo BCT, Nikkiso

The Plasmapheresis Machines research report studies primary and secondary research in order to analyze the data effectively. The market study further also draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company

OpenPR | December 3, 2022

Fresenius Medical Care AG & Co. KGaA's (ETR:FME) top owners are individual investors with 38% stake, while36% is held by institutions

A look at the shareholders of Fresenius Medical Care AG & Co. KGaA ( ETR:FME ) can tell us which group is most...

Yahoo | November 24, 2022

Should You Now Sell Fresenius Medical Care AG & Co. KGaA (FMS)?

Artisan Partners, an investment management company, released its “Artisan Value Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund underperformed its benchmark index. Its Investor Class fund ARTLX returned -7.04%, Advisor Class fund APDLX posted a return of -7.07%, and Institutional Class fund APHLX […]

Insider Monkey | November 16, 2022

3 Stocks With Dividends of 3% or More to Buy on the Dip

Fresenius Medical Care (NYSE: FMS), Pfizer (NYSE: PFE), and Viatris (NASDAQ: VTRS) have seen their shares slide so far this year. Fresenius, a German company that specializes in healthcare services for kidney dialysis patients, has seen its shares fall more than 54% this year. Fresenius reported third-quarter numbers on Nov. 1, and the results were mixed.

Yahoo | November 14, 2022

Douglas Dynamics and Fresenius Medical have been highlighted as Zacks Bull and Bear of the Day

Douglas Dynamics and Fresenius Medical have been highlighted as Zacks Bull and Bear of the Day.

Yahoo | November 11, 2022

Bear of the Day: Fresenius Medical (FMS)

Profit estimates are moving in the wrong direction.

Yahoo | November 11, 2022

Fresenius Medical Care KGaA Third Quarter 2022 Earnings: Beats Expectations

Fresenius Medical Care KGaA ( ETR:FME ) Third Quarter 2022 Results Key Financial Results Revenue: €5.10b (up 15% from...

Yahoo | November 8, 2022

Fresenius Medical's (FMS) Q3 Earnings and Revenues Top

Fresenius Medical's (FMS) third-quarter revenues benefit from strong performance across all the geographic regions and segments. However, rising costs hurt margins.

Yahoo | November 2, 2022

Fresenius Medical Care KGaA (ETR:FME) shareholders have endured a 64% loss from investing in the stock five years ago

Generally speaking long term investing is the way to go. But that doesn't mean long term investors can avoid big...

Yahoo | November 1, 2022

Earnings Outlook For Fresenius Medical Care

Fresenius Medical Care (NYSE: FMS ) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here''s what investors need to know before the announcement. Analysts estimate that Fresenius Medical Care will report an earnings per share (EPS) of $0.33. Fresenius Medical Care bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, … Full story available on

Benzinga | October 31, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5908 seconds.